As presented in Figure 3, our results and the obtained ROC (receiver operating characteristic) curve, indicate that increased p16 expression may be a reliable marker of IBC progression (area under the receiver operating characteristic, AUROC = 0.770; p < 0.0005). This evidence concerns the gene CDKN2A and inflammatory breast carcinoma.